Dr Lal Path Labs reported a 28.02 percent year-on-year rise in consolidated net profit to Rs 169.5 crore in the April-June quarter of FY27 from Rs 132.4 crore a year ago ...
Earnings call Dr. Lal PathLabs reported 10.7% YoY revenue growth and 19.3% PAT growth in Q3 FY25, despite no price increases. The company is executing a multi-pronged strategy of geographic expansion, ...
Dr Lal Path Labs shares surged after a strong Q1FY27 earnings beat, driven by higher realisations and price hikes. Brokerages ...
Bengaluru: Dr. Lal Path Labs reported a lower third-quarter profit on Friday after taking a one-time charge linked to India's new labour code, despite strong demand for its bundled test packages.
April 25 (Reuters) - Dr Lal Path Labs (DLPA.NS), opens new tab, India's largest diagnostics firm by revenue, reported fourth-quarter profit above expectations on Friday as strong demand for its ...
Dr. Lal Path Labs shares have shown a steady upward trend across most timeframes, outperforming the broader Nifty 500 and reflecting strong investor interest around the company’s growth outlook and ...
Earnings call Dr. Lal PathLabs reported FY25 revenue of ₹2,461 crore, up 10.5% YoY, with PAT rising 35.9% to ₹492 crore (including a one-time tax benefit). Q4 margins expanded, but FY26 guidance ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results